Our research program endeavours to determine the molecular events driving brain cancer, and to translate observations from our genetic model systems to the clinic. We have established the clinical-research networks underpinning the Canberra Brain Cancer Collaborative (CBCC). We established the ACT Brain Cancer Biobank (ABCB) as the first Canberra node of Brain Cancer Biobanking Australia (BCBA) to enable the drug discovery pipelines to fast-track efficacious therapeutics to the clinic to improve patient outcomes.